<div style="margin:20px;margin-top:5px;">
<div class="smallfont" style="margin-bottom:2px;">Quote:</div>
<table border="0" cellpadding="6" cellspacing="0" width="99%"><tr><td class="alt2" style="border:1px inset;">
<div>Originally Posted by <strong>amnesiac</strong> <a href="/community/forum/post/11263326"><img alt="View Post" class="inlineimg" src="/community/img/forum/go_quote.gif" style="border:0px solid;"></a></div>
<div style="font-style:italic;">That's specifically what I was curious to hear discussion about - how their recommendations may or may not speak to that issue...</div>
</td>
</tr></table></div>
What they say is:<br><br><div style="margin:20px;margin-top:5px;">
<div class="smallfont" style="margin-bottom:2px;">Quote:</div>
<table border="0" cellpadding="6" cellspacing="0" width="99%"><tr><td class="alt2" style="border:1px inset;">Vaccinating adults and adolescents using Tdap reduces the<br>
burden of pertussis among vaccine recipients and <b><i>might</i></b> prevent<br>
transmission of B. pertussis to infants (1,2).</td>
</tr></table></div>
Then their references are older MMWR recommendations. Tracking the original research down (IME) tends to be an exercise in futility for these things. They either cherry pick some obscure unreproduced findings from the 1970's or cite a study where an "expert panel" (of vaccinologists) was convened to make a wild guess.<br><br>
Anywho...<br>
This isn't any different from what they've been recommending all along.<br>
They just left out the part about how HCPs who vax pregnant women are supposed to call 1-800-vaccine so the manufacturers can put a study together saying it's totally safe, so the ACIP can them make a firm recommendation instead of this wishy-washy "not contraindicated, but not recommended, exactly" stuff.<br>
This is just another stepping stone for universal use in pregnancy.<br><br>
I like how they word this:<br><br><div style="margin:20px;margin-top:5px;">
<div class="smallfont" style="margin-bottom:2px;">Quote:</div>
<table border="0" cellpadding="6" cellspacing="0" width="99%"><tr><td class="alt2" style="border:1px inset;">Health-care personnel who have not been vaccinated with<br>
Tdap (Table 2) can be an important source of pertussis and<br>
pertussis outbreaks in obstetric and neonatal settings.</td>
</tr></table></div>
They don't out-right <i>claim</i> that HCPs who get the TDaP won't generally transmit the organism....they just <i>imply</i> it.<br><br>
Oh, wait...reading the bottom...they did say call the registry:<br><br><div style="margin:20px;margin-top:5px;">
<div class="smallfont" style="margin-bottom:2px;">Quote:</div>
<table border="0" cellpadding="6" cellspacing="0" width="99%"><tr><td class="alt2" style="border:1px inset;">Because information on the use of Tdap in pregnant women<br>
is lacking, both manufacturers of Tdap have established a pregnancy<br>
registry. Health-care providers are encouraged to<br>
report vaccination of pregnant women with Tdap, regardless<br>
of trimester, to the appropriate manufacturer’s registry. For<br>
ADACEL,® vaccination should be reported to sanofi pasteur,<br>
telephone 1-800-822-2463 (1-800-VACCINE), and for<br>
BOOSTRIX,® vaccination should be reported to<br>
GlaxoSmithKline Biologicals, telephone 1-888-825-5249.</td>
</tr></table></div>
I'd be surprised if the purpose of that wasn't to let the manufacturer produce the data on it's 100% safety, to justify universal use in pregnant women.